Stay updated on Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    New page revision: v3.3.4 replaces v3.3.3. This is a minor technical update that does not affect the study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:21:36.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    New locations across the US, Australia, Canada, Denmark, Spain, and Poland were added. Several outcome/timeframe definitions were updated to reflect revised monitoring periods (e.g., up to approximately 93 months).
    Difference
    2%
    Check dated 2025-12-24T13:47:00.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added 'Prostate cancer' as a topic and 'MedlinePlus Genetics' as a related topic. These are tagging/related-topic changes and do not modify the study details or page workflow. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-16T22:24:25.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The Publications section now indicates that publications are automatically filled from PubMed and may not be about the study, and the Revision version has been updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:45.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Removal of the government funding operating status notice from the page. The notice previously informed users about potential delays and directed to cc.nih.gov and opm.gov for updates.
    Difference
    0.2%
    Check dated 2025-11-18T07:23:38.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Changes are limited to minor UI/layout tweaks and an updated last-updated timestamp; no core study information was altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-27T21:01:15.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page.